Lv7 热心小伙伴
5001 积分 2021-08-06 加入
呱
Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engager
10天前
已完结
Tarlatamab: First Approval
10天前
已完结
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia
16天前
已完结
Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective Study
23天前
已完结
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms
23天前
已完结
Chronic lymphocytic leukemia: what clinical progress have we seen in the last five years?
23天前
已完结
Updates in the management of newly diagnosed chronic lymphocytic leukemia
23天前
已完结
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial
1个月前
已完结
Genomic Profiling of Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung Cancer after Progression on First-line Osimertinib: Phase II ORCHARD Study
1个月前
已关闭
OA10.04 Phase II Study of Iza-Bren (BL-B01D1) Combo With Osimertinib in EGFR Mutated Locally Advanced or Metastatic NSCLC Patients
1个月前
已完结
皖公网安备34019202002308
